Physician profile
Darrell R New
NPI 1235505827
$2,567.13
in general payments reported to CMS, 2019-2025
30 companies · $423 in 2025
The $423 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $524 · 2022: $447 · 2023: $365 · 2024: $809 · 2025: $423.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,596.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $524.44 | 2021-2025 | |
| Astrazeneca Pharmaceuticals Lp | $238.93 | 2023-2025 | Airsupra, Farxiga, Breztri |
| Novo Nordisk INC | $229.63 | 2021-2025 | Wegovy |
| Amgen INC. | $215.11 | 2022-2025 | Otezla, Repatha, Evenity |
| Boehringer Ingelheim Pharmaceuticals, INC. | $180.81 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $178.38 | 2021-2025 | Rexulti |
| Lundbeck LLC | $175.64 | 2023-2024 | Rexulti, Vyepti |
| Pfizer INC. | $86.89 | 2021-2022 | |
| Lilly USA, LLC | $84.76 | 2021-2025 | Mounjaro, Zepbound |
| Baxter Healthcare | $66.28 | 2023-2024 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System, Hillrom - Monarch Airway Clearance System |
| Janssen Pharmaceuticals, INC | $51.67 | 2021-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $49.24 | 2024 | |
| Merck Sharp & Dohme LLC | $45.27 | 2022 | |
| Abbott Laboratories | $40.90 | 2022 | |
| Corium, LLC | $40.86 | 2024 | Azstarys |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Uswm, LLC | $37.90 | 2022 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $36.14 | 2022-2025 | Caplyta |
| Phathom Pharmaceuticals, INC. | $35.09 | 2024-2025 | Voquezna |
| Collegium Pharmaceutical, INC. | $33.26 | 2024 | Belbuca |
| Idorsia Pharmaceuticals US INC | $31.96 | 2022-2023 | Quviviq |
| Astellas Pharma US INC | $27.35 | 2023 | Veozah, Myrbetriq |
| Ultragenyx Pharmaceutical INC. | $24.20 | 2024 | Crysvita |
| Xeris Pharmaceuticals, INC. | $20.68 | 2023 | Gvoke Hypopen |
| Exact Sciences Corporation | $20.31 | 2025 | Cologuard Collection Kit |
| Philips North America LLC | $17.58 | 2024 | (Ck4) Mcot |
| Ironshore Pharmaceuticals INC. | $17.18 | 2021 | |
| Inspire Medical Systems, INC. | $17.08 | 2025 | Inspire |
| Bayer Healthcare Pharmaceuticals INC. | $15.28 | 2022 | |
| Almatica Pharma LLC | $13.33 | 2022 | |
| Genentech USA, INC. | $10.98 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell New listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.